Omada Health (NASDAQ:OMDA) CEO Sells $327,175.20 in Stock

Omada Health, Inc. (NASDAQ:OMDAGet Free Report) CEO Sean Duffy sold 14,960 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.87, for a total value of $327,175.20. Following the completion of the sale, the chief executive officer directly owned 382,594 shares of the company’s stock, valued at $8,367,330.78. The trade was a 3.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Omada Health Stock Performance

Shares of NASDAQ:OMDA opened at $19.76 on Thursday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The business’s 50 day simple moving average is $22.45 and its two-hundred day simple moving average is $18.14. The firm has a market cap of $1.21 billion, a P/E ratio of 395.20 and a beta of 1.86.

Omada Health (NASDAQ:OMDAGet Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The firm had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. On average, equities analysts forecast that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

OMDA has been the topic of several research reports. Morgan Stanley restated an “overweight” rating and set a $30.00 price objective on shares of Omada Health in a report on Monday, June 22nd. JPMorgan Chase & Co. raised their price target on shares of Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Robert W. Baird lifted their price target on Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday, August 12th. BTIG Research reissued a “buy” rating and set a $35.00 price objective on shares of Omada Health in a report on Friday, September 11th. Finally, Citizens Jmp raised their target price on Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a report on Friday, August 14th. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $26.67.

Get Our Latest Analysis on OMDA

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. WINTON GROUP Ltd bought a new stake in Omada Health in the 2nd quarter worth about $1,101,000. Integrated Wealth Concepts LLC bought a new position in shares of Omada Health during the 2nd quarter worth approximately $53,000. Squarepoint Ops LLC bought a new position in shares of Omada Health during the 2nd quarter worth approximately $2,044,000. Corient Private Wealth LP boosted its stake in shares of Omada Health by 252.5% in the 2nd quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock worth $3,185,000 after buying an additional 103,955 shares during the last quarter. Finally, Round Rock Advisors LLC bought a new position in shares of Omada Health in the second quarter valued at approximately $745,000.

Omada Health Company Profile

(Get Free Report)

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.

Further Reading

Insider Buying and Selling by Quarter for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.